Catalyst
Slingshot members are tracking this event:
Radius Health (RDUS) Submits New Drug Application (NDA) to FDA for Abaloparatide-SC for the Treatment of Postmenopausal Women with Osteoporosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RDUS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 30, 2016
Related Projects
Related Keywords
New Drug Application, Fda, Abaloparatide-sc, Postmenopausal Women, Osteoporosis
